Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme -- Ignore unavailable to you. Want to Upgrade?

To: brasilbound who wrote (4761)	6/17/1998 3:23:00 PM
From: margaret foley	Read Replies (1) \| Respond to of 8798

ZD-OPTIONS???symbol? I am looking for the options symbols and cboe is not working for me. Thanks.

To: brasilbound who wrote (4761)	6/18/1998 1:50:00 AM
From: Zakattack	Read Replies (1) \| Respond to of 8798

RMGG... News! Here it is... Sorry for the delayed response - was out of the office discussing ARET... (Folks ARET is another real co, I'm expecting a minimum of 1200% increase in price over the next few weeks <moo>): biz.yahoo.com Wednesday June 17, 6:00 pm Eastern Time Company Press Release Litchfield buys 25% of Rocky Mountain Ginseng VANCOUVER--(BUSINESS WIRE)--June 17, 1998--In addition to Litchfield Continental Ltd.'s commitment to finance RMGG's acquisition of a Chinese pharmaceutical company (see news release dated April 8, 1998), Litchfield has committed to purchase 5 million shares (25% of the issued) of RMGG from Kettle Mountain Ginseng Company Ltd. The investment by Litchfield in RMGG complements Litchfield's investment in Global Spill Management (GEGI - OTC BB). (GEGI symbol to change to BIOF June 18, 1998). Global Spill is acquiring Biofarm S.A., a pharmaceutical company, which will use RMGG's distribution network particularly in China as a strategic and integral part of its global pharmaceutical and health related product lines. Additionally, RMGG is negotiating with Chinese suppliers to provide raw materials to Biofarm's European pharmaceutical plant. The contract is expected to generate in excess of $1 million of revenues annually for RMGG. With China importing over 4 million pounds of American ginseng annually, RMGG's acquisition of Fuzhou Fujiang Drugs Co., Ltd. will open the Chinese ginseng market to RMGG. 100% ownership of the FF Co. will give RMGG the business licences necessary to import and manufacture American ginseng products in China. RMGG will assume distribution to the 130 plus sales outlets FF Co. maintains in major Chinese cities. Kettle Mountain, one of the founders of RMGG, will continue to focus primarily on its agricultural business of growing ginseng and will continue to use RMGG as its marketing and distributing force. As part of the transaction, Mr. Doug Bullock has resigned as president and director of RMGG and he continues as president, director and chief operating officer of Kettle Mountain. Mr. Robert Bell has been appointed president and director of RMGG. For further information and updates, please send us your e-mail address to rlbell@direct.ca. The statements made in this news release may contain certain forward looking statements. Actual events or results may differ from the Company's expectations. Certain risk factors may also affect the results achieved by the Company. Contact: Rocky Mountain Ginseng, Inc. Robert Bell, 604/420-0095